Iron overload in cirrhosis - HFE genotypes and outcome after liver transplantation

Hepatology

Volumn 31, Issue 2, 2000, Pages 456-460

  Brandhagen, David J ^a   Alvarez, William ^a   Therneau, Terry M ^a   Kruckeberg, Kent E ^a   Thibodeau, Stephen N ^a   Ludwig, Jurgen ^a   Porayko, Michael K ^a,b  

^a MAYO CLINIC   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DNA; IRON; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GRAFT SURVIVAL; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; INFECTION; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033966158     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310227     Document Type: Article

References (13)

1. Bassett M, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. HEPATOLOGY 1986;6:24-29.
2. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WE Hemosiderosis in cinhosis: a study of 447 native livers. Gastroenterology 1997;112:882-888.
3. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley KV. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-262.
4. Deugnier Y, Turlin B, Quilleuc D, Moirand R, Loreal O, Messer M, Meunier B, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997;21:669-675.
5. Kowdley KV, Hassanein T, Kaur S, Farnell FJ, Van Thiel DH, Keeffe EB, Sorrell MF, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995;1:237-241.
6. Farrell F, Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, Esquivel CO, et al. Outcome of liver transplantation in patients with hemochromatosis. HEPATOLOGY 1994;20:404-410.
7. Pillay P, Tzoracoleftherakis E, Tzakis AG, Kakizoe S, Van Thiel DH, Starzl TE. Orthotopic liver transplantation for hemochromatosis. Transplant Proc 1991;23:1888-1889.
8. Fagiuoli S, Hassanein T, Guraker A, Caraceni P, Wright HI, Tabasco-Miguillan J, Gavaler JS, et al. Liver transplantation for hereditary hemochromatosis (HHC) [Abstract]. Gastroenterology 1993;104:A898.
9. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993;56:554-561.
10. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al. A novel MHC class Hike gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
11. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22:187-194.
12. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, et al. Letter; comment. Nat Genet 1996;14:249-251.
13. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouang J, Mosser J, et al. Letter; comment. Nat Genet 1996;14:251-252.